LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $206,000 | -48.4% | 1,353 | -57.4% | 0.02% | -50.0% |
| Q1 2019 | $399,000 | -72.0% | 3,175 | -63.2% | 0.03% | -56.2% |
| Q1 2018 | $1,423,000 | +22.5% | 8,618 | +1.6% | 0.07% | +23.7% |
| Q4 2017 | $1,162,000 | +3.8% | 8,484 | +3.3% | 0.06% | -3.3% |
| Q3 2017 | $1,119,000 | +7.1% | 8,215 | -4.6% | 0.06% | +1.7% |
| Q2 2017 | $1,045,000 | +15.3% | 8,609 | +0.6% | 0.06% | +13.2% |
| Q1 2017 | $906,000 | -17.8% | 8,558 | -21.1% | 0.05% | -23.2% |
| Q4 2016 | $1,102,000 | -14.3% | 10,849 | -13.9% | 0.07% | -15.9% |
| Q3 2016 | $1,286,000 | -14.4% | 12,604 | +0.1% | 0.08% | -19.6% |
| Q2 2016 | $1,502,000 | +17.9% | 12,593 | +5.8% | 0.10% | +10.9% |
| Q1 2016 | $1,274,000 | – | 11,899 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |